BioCryst Pharmaceuticals
BCRX
#4934
Rank
$1.96 B
Marketcap
$7.65
Share price
1.59%
Change (1 day)
5.81%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - P/B ratio

P/B ratio as of November 2026 : -4.33

According to BioCryst Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 2.04713.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioCryst Pharmaceuticals - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-31-13.3295.32%
2024-12-31-3.3624.59%
2023-12-31-2.69-62.93%
2022-12-31-7.26-68.81%
2021-12-31-23.3-65.89%
2020-12-31-68.3-591.41%
2019-12-3113.9-22.97%
2018-12-3118.0212.76%
2017-12-315.77-98.05%
2016-12-312961765.24%
2015-12-3115.937.12%
2014-12-3111.6-102.9%
2013-12-31-399150.56%
2012-12-31-159-2210.4%
2011-12-317.54112.56%
2010-12-313.557.92%
2009-12-313.29191.24%
2008-12-311.13-68.77%
2007-12-313.62-77.38%
2006-12-3116.093.53%
2005-12-318.2692.63%
2004-12-314.29-0.37%
2003-12-314.30918.74%
2002-12-310.4224

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Gilead Sciences
GILD
17.9-513.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
4.16-196.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
1.17-127.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
5.22-220.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-8.64 99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.31-176.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
4.06-193.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
2.10-148.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.9096-120.99%๐Ÿ‡บ๐Ÿ‡ธ USA